Back to News
Market Impact: 0.08
Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients with Wet Age-Related Macular Degeneration
Source: PR Newswire
Healthcare & Biotech
Kodiak Sciences announced it will host a webcast on September 28, 2026, at 8:30 a.m. ET. The excerpt provides no clinical, financial, operational, or guidance update, limiting its expected market relevance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.00
More News
- Wall Street Week | China’s Trade Reckoning, Syracuse’s Second Chance, Humanoids in Healthcare
- Yields keep rising, Novo's tough week, why cat product sales are surging and more in Morning Squawk
- Details on U.S.-China trade negotiations coming Monday, USTR Greer says
- At Meta Connect, the company’s smart glasses were everywhere
- ShinyHunters tells The Reg: We hacked the FBI to 'protect our business'
- For months, OpenAI’s agent swarms have been attacking online databases to find obscure facts